Natural Baicalein-Rich Fraction as Radiosensitizer in Combination with Bismuth Oxide Nanoparticles and Cisplatin for Clinical Radiotherapy.

Noor Nabilah Talik Sisin Nor Fazila Che Mat Raizulnasuha Ab RashidNorhayati DollahKhairunisak Abdul Razak Moshi GesoMerfat AlgethamiWan Nordiana Rahman

Published in: International journal of nanomedicine (2022)

The BRF is found to induce relatively less radiosensitization effects compared to the BiONPs and Cis. The BB and BCB combinations have shown better effects with potential for becoming competently suitable radiosensitizers in breast cancer therapies.

Keyphrases

oxide nanoparticles
early stage
young adults
risk assessment
childhood cancer